NICHD follows overall NIH policies and guidelines on many topics, but also issues its own policies on specific topics. These policies help guide how the institute handles a range of different research issues such as human subjects protection, data sharing, large grants, and administrative supplements.
Clinical Research (Includes Human Subjects, Inclusion, & Safety Monitoring)
These policies provide guidance on the conduct of various aspects of clinical research, including entries into clinicaltrials.gov, inclusion of different groups, protections for human subjects, and management of data safety and monitoring activities. Check out the newly added NICHD Extramural Clinical Trials Monitoring and Oversight Policy (PDF 468 KB).
NICHD Policies and Procedures on Clinical Research and Related Issues
Large Grants
NIH and NICHD provide policy guidance to applicants planning to submit any application requesting $500,000 or more in direct costs for any one year.
NICHD Policy on Large Grants
NIH Policy on Large Grants
Special Council Review (SCR)
NEW: In 2023, NICHD updated its SCR policy for projects or grantees with $1 million in total costs (inclusive of direct and indirect costs).
Stem Cells
These policies govern the use of stem cells for research purposes.
Supplements
NICHD provides guidance to applicants on the submission of requests for additional funding to an active NICHD grant to support activities that fall within the original scope of the project.
NICHD Policy and Procedures for Administrative Supplements
Overarching Policies
NICHD also follows these NIH and HHS policies related to its research and activities.
- Animal Welfare: NIH Office of Laboratory Animal Welfare regulates the use of animals for research.
- Conflict of Interest: Financial conflict of interest is governed by NIH policy.
- Public Access, Intellectual Property, and Data-Sharing Policies: These NIH policies address issues related to research data and findings.
- Research Grants: NIH policies provide guidance on the steps involved in the planning, development, implementation, and follow-through of grant and cooperative agreement applications, including understanding the compliance obligations of a grant award and the proper use of grant funds.
- Research Integrity: NIH and HHS are fully committed to maintaining public trust in the research enterprise by supporting grantees in adhering to the highest standards of research integrity.
- Select and Infectious Agents: NIH is responsible for monitoring and oversight of the submissions and awards process for extramural research involving infectious agents and select agents, as well as processes for investigations of accidents, research-related illnesses, and potential biosafety violations.
- Submitting an Application: These NIH and HHS policies relate to preparing and submitting an application:
- Revised Policy on the Acceptance for Review of Unsolicited Applications That Request $500,000 or More in Direct Costs
- Allowability of Facilities and Administrative (F&A) Costs for Foreign and International Organizations
- NIH Announces Revised Policy: Applications that Include Consortium/Contractual Facilities and Administrative Costs
- NIH Policy on Late Submission of Grant Applications
- Salary Limitation on Grants, Cooperative Agreements, and Contracts
- Electronic Submission Process Now Available for Administrative Supplement Requests
- Implementation of the Research Performance Progress Report (RPPR)
BACK TO TOP